Zhongjian Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhongjian Xie has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Han Zhang
Department of Gastroenterology, Zigong First People’s Hospital, Zigong, China
2 shared publications - Zhi Chen
Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences
2 shared publications - Albert Yu
Faculty of Materials Science, Shenzhen MSU-BIT University, Shenzhen 518172, China
1 shared publication Asif Mahmood
School of Chemical and Biomolecular Engineering The University of Sydney Sydney 2006 Australia
1 shared publicationAyesha Khan Tareen
School of Mechanical Engineering Dongguan University of Technology Dongguan 523808 China
1 shared publicationBowen Du
College of Physics and Optoelectronic Engineering, Interdisciplinary Center of High Magnetic Field, Physics, Shenzhen University, Shenzhen 518060, P.R. China
1 shared publication
Latest Publications
- Open Access
- 2 March 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (3) , 319
Repurposing Conventional Magnetic Functional Agents: A Novel Strategy for Long-Acting, Safe, Magnetically Mediated Precision Oncology
Background: Although conventional magnetic functional agents provide a material basis for magnetically mediated tumor therapy, they have long been restricted by the application framework of magnetic resonance imaging (MRI) or magnetic thermal ablation. Methods: This study proposed a repurposing strategy of two mature magnetic functional agents, Fe3O4 nanoparticles and gadopentetic acid (GA), by applying their unique magnetic response properties to enhance magnetic field therapy for glioma. Results: Both magnetic materials, when combined with an external magnetic field (MF), showed a synergistic effect to amplify the therapeutic effect. In the CT-2A glioma-bearing mice model, it resulted in marked suppression of tumor growth, with the growth inhibition (TGI) rate increasing from ~27% after MF therapy alone to 64% and 55% after the Fe3O4- and GA-potentiated MF therapy, respectively. It was proposed that the MF effect on impairing tumor angiogenesis was enhanced, as evidenced by significant reductions in CD31 expression and microvessel density. It disrupted nutrient supply to the tumor, augmenting the tumor suppression efficiency. The reduced infiltration of CD4+ and CD8+ T cells into tumors further confirmed the effective blockade of tumor perfusion. Conclusions: This study established a new paradigm of conventional magnetic materials to enhance the non-thermal physical effects and biological regulatory effects of magnetic field for glioma therapy, instead of only as the imaging agents or magnetic hyperthermia agents.
- 2 March 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (3) , 319
Open AccessRepurposing Conventional Magnetic Functional Agents: A Novel Strategy for Long-Acting, Safe, Magnetically Mediated Precision Oncology
Background: Although conventional magnetic functional agents provide a material basis for magnetically mediated tumor therapy, they have long been restricted by the application framework of magnetic resonance imaging (MRI) or magnetic thermal ablation. Methods: This study proposed a repurposing strategy of two mature magnetic functional agents, Fe3O4 nanoparticles and gadopentetic acid (GA), by applying their unique magnetic response properties to enhance magnetic field therapy for glioma. Results: Both magnetic materials, when combined with an external magnetic field (MF), showed a synergistic effect to amplify the therapeutic effect. In the CT-2A glioma-bearing mice model, it resulted in marked suppression of tumor growth, with the growth inhibition (TGI) rate increasing from ~27% after MF therapy alone to 64% and 55% after the Fe3O4- and GA-potentiated MF therapy, respectively. It was proposed that the MF effect on impairing tumor angiogenesis was enhanced, as evidenced by significant reductions in CD31 expression and microvessel density. It disrupted nutrient supply to the tumor, augmenting the tumor suppression efficiency. The reduced infiltration of CD4+ and CD8+ T cells into tumors further confirmed the effective blockade of tumor perfusion. Conclusions: This study established a new paradigm of conventional magnetic materials to enhance the non-thermal physical effects and biological regulatory effects of magnetic field for glioma therapy, instead of only as the imaging agents or magnetic hyperthermia agents.
- Open Access
- 24 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
A CRISPR-assisted passive microfluidic chip for rapid, visual detection of multiple respiratory viruses
In recent years, viral co-infections, particularly with respiratory viruses, have resulted in more complex symptoms, a greater disease burden, and increased challenges in clinical decision-making. These complexities underscore the urgent need for improved diagnostic tools in the managing acute respiratory infections. To address the limitations of conventional qPCR and current POCT methodologies, we developed a passively driven microfluidic chip capable of rapidly screening multiple respiratory viruses. This platform is particularly suited for the point-of-care diagnosis of viral co-infections. Our device integrates nucleic acid amplification and CRISPR-based detection within a single, passively operated system. By utilizing a rapid, 10-minute sample preparation protocol and a 35-minute on-chip assay, this platform enables the multiplex detection of influenza A/B, human parainfluenza virus, and SARS-CoV-2. The total assay time from sample to answer is approximately 45 min, with equipment requirements minimized to a heating block. The assay demonstrated a detection sensitivity of about 10 copies/µL for viral RNA in dilution series experiments. The sensitivity of the assay was 98.44% (95% CI: 91.6%–99.96%), and the specificity was 100% (95% CI: 79.4%–100%). The system combines CRISPR-Cas12a-mediated sensing with reverse transcription recombinase polymerase amplification (RPA) for highly specific nucleic acid detection. The chip design utilizes capillary action and gravity-driven flow for autonomous fluid control, while lyophilized reagent preloading ensures storage stability and minimizes user intervention.
- 24 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessA CRISPR-assisted passive microfluidic chip for rapid, visual detection of multiple respiratory viruses
In recent years, viral co-infections, particularly with respiratory viruses, have resulted in more complex symptoms, a greater disease burden, and increased challenges in clinical decision-making. These complexities underscore the urgent need for improved diagnostic tools in the managing acute respiratory infections. To address the limitations of conventional qPCR and current POCT methodologies, we developed a passively driven microfluidic chip capable of rapidly screening multiple respiratory viruses. This platform is particularly suited for the point-of-care diagnosis of viral co-infections. Our device integrates nucleic acid amplification and CRISPR-based detection within a single, passively operated system. By utilizing a rapid, 10-minute sample preparation protocol and a 35-minute on-chip assay, this platform enables the multiplex detection of influenza A/B, human parainfluenza virus, and SARS-CoV-2. The total assay time from sample to answer is approximately 45 min, with equipment requirements minimized to a heating block. The assay demonstrated a detection sensitivity of about 10 copies/µL for viral RNA in dilution series experiments. The sensitivity of the assay was 98.44% (95% CI: 91.6%–99.96%), and the specificity was 100% (95% CI: 79.4%–100%). The system combines CRISPR-Cas12a-mediated sensing with reverse transcription recombinase polymerase amplification (RPA) for highly specific nucleic acid detection. The chip design utilizes capillary action and gravity-driven flow for autonomous fluid control, while lyophilized reagent preloading ensures storage stability and minimizes user intervention.
- Open Access
Rigid DNA Frameworks Anchored Transistor Enabled Ultrasensitive Detection of Aβ-42 in Serum
It is significant to search for ultrasensitive and accurate testing technology for point-of-care monitoring of common diseases at home; for example, monitoring the Aβ-42 level at any time is crucial for patients suffering from Alzheimer’s disease. However, accurately monitoring the Aβ-42 level in serum is often thwarted by the challenges in sensitivity and specificity due to the multiplicated contaminations and intricated biofluid environments. Here, we develop a graphene field-effect transistor (G-FET) sensor modified with a type of rigid DNA framework aptamer—tetrahedral DNA nanostructure (TDN) for Aβ-42 detection in serum. The Aβ-42 specific aptamer combined with the rigid tetrahedral nanostructure achieves higher binding affinity and better specificity and anti-fouling ability. The detectable concentration reaches 5 × 10−18 mol L−1 in serum, lower than most other assay approaches. Moreover, the sensor rapidly detects the Aβ-42 level in 6 supernatant samples from mice blood within 5 min and achieves high accuracy. This sensitive and specific method enabled by the DNA tetrahedron G-FET sensor has great potential in the monitoring of Alzheimer’s disease and other diseases.
Open AccessRigid DNA Frameworks Anchored Transistor Enabled Ultrasensitive Detection of Aβ-42 in Serum
It is significant to search for ultrasensitive and accurate testing technology for point-of-care monitoring of common diseases at home; for example, monitoring the Aβ-42 level at any time is crucial for patients suffering from Alzheimer’s disease. However, accurately monitoring the Aβ-42 level in serum is often thwarted by the challenges in sensitivity and specificity due to the multiplicated contaminations and intricated biofluid environments. Here, we develop a graphene field-effect transistor (G-FET) sensor modified with a type of rigid DNA framework aptamer—tetrahedral DNA nanostructure (TDN) for Aβ-42 detection in serum. The Aβ-42 specific aptamer combined with the rigid tetrahedral nanostructure achieves higher binding affinity and better specificity and anti-fouling ability. The detectable concentration reaches 5 × 10−18 mol L−1 in serum, lower than most other assay approaches. Moreover, the sensor rapidly detects the Aβ-42 level in 6 supernatant samples from mice blood within 5 min and achieves high accuracy. This sensitive and specific method enabled by the DNA tetrahedron G-FET sensor has great potential in the monitoring of Alzheimer’s disease and other diseases.
- 6 November 2024
- Published by American Chemical Society (ACS) in ACS Photonics
- Vol. 11 (11) , 4948-4957
Single-Base Resolution Photonic-Integrated Chips via Hybrid Dielectric–Metal Nanocavities for Ultrasensitive Multichannel Biosensing
- 6 November 2024
- Published by American Chemical Society (ACS) in ACS Photonics
- Vol. 11 (11) , 4948-4957
Single-Base Resolution Photonic-Integrated Chips via Hybrid Dielectric–Metal Nanocavities for Ultrasensitive Multichannel Biosensing
- Open Access
- 18 June 2024
- Published by Wiley in Advanced Science
- Vol. 11 (36) , e2303998
Recent Advances in Non‐Ti MXenes: Synthesis, Properties, and Novel Applications
One of the most fascinating 2D nanomaterials (NMs) ever found is various members of MXene family. Among them, the titanium‐based MXenes, with more than 70% of publication‐related investigations, are comparatively well studied, producing fundamental foundation for the 2D MXene family members with flexible properties, familiar with a variety of advanced novel technological applications. Nonetheless, there are still more candidates among transitional metals (TMs) that can function as MXene NMs in ways that go well beyond those that are now recognized. Systematized details of the preparations, characteristics, limitations, significant discoveries, and uses of the novel M‐based MXenes (M‐MXenes), where M stands for non‐Ti TMs (M = Sc, V, Cr, Y, Zr, Nb, Mo, Hf, Ta, W, and Lu), are given. The exceptional qualities of the 2D non‐Ti MXene outperform standard Ti‐MXene in several applications. There is many advancement in top‐down as well as bottom‐up production of MXenes family members, which allows for exact control of the M‐characteristics MXene NMs to contain cutting‐edge applications. This study offers a systematic evaluation of existing research, covering everything in producing complex M‐MXenes from primary limitations to the characterization and selection of their applications in accordance with their novel features. The development of double metal combinations, extension of additional metal candidates beyond group‐(III–VI)B family, and subsequent development of the 2D TM carbide/TMs nitride/TM carbonitrides to 2D metal boride family are also included in this overview. The possibilities and further recommendations for the way of non‐Ti MXene NMs are in the synthesis of NMs will discuss in detail in this critical evaluation.
- 18 June 2024
- Published by Wiley in Advanced Science
- Vol. 11 (36) , e2303998
Open AccessRecent Advances in Non‐Ti MXenes: Synthesis, Properties, and Novel Applications
One of the most fascinating 2D nanomaterials (NMs) ever found is various members of MXene family. Among them, the titanium‐based MXenes, with more than 70% of publication‐related investigations, are comparatively well studied, producing fundamental foundation for the 2D MXene family members with flexible properties, familiar with a variety of advanced novel technological applications. Nonetheless, there are still more candidates among transitional metals (TMs) that can function as MXene NMs in ways that go well beyond those that are now recognized. Systematized details of the preparations, characteristics, limitations, significant discoveries, and uses of the novel M‐based MXenes (M‐MXenes), where M stands for non‐Ti TMs (M = Sc, V, Cr, Y, Zr, Nb, Mo, Hf, Ta, W, and Lu), are given. The exceptional qualities of the 2D non‐Ti MXene outperform standard Ti‐MXene in several applications. There is many advancement in top‐down as well as bottom‐up production of MXenes family members, which allows for exact control of the M‐characteristics MXene NMs to contain cutting‐edge applications. This study offers a systematic evaluation of existing research, covering everything in producing complex M‐MXenes from primary limitations to the characterization and selection of their applications in accordance with their novel features. The development of double metal combinations, extension of additional metal candidates beyond group‐(III–VI)B family, and subsequent development of the 2D TM carbide/TMs nitride/TM carbonitrides to 2D metal boride family are also included in this overview. The possibilities and further recommendations for the way of non‐Ti MXene NMs are in the synthesis of NMs will discuss in detail in this critical evaluation.
- 3 May 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 370, 339-353
Injectable hydrogel harnessing foreskin mesenchymal stem cell-derived extracellular vesicles for treatment of chronic diabetic skin wounds
- 3 May 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 370, 339-353
Injectable hydrogel harnessing foreskin mesenchymal stem cell-derived extracellular vesicles for treatment of chronic diabetic skin wounds
- 26 March 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 655, 124015
Ultrasound imaging guided targeted sonodynamic therapy enhanced by magnetophoretically controlled magnetic microbubbles
- 26 March 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 655, 124015
Ultrasound imaging guided targeted sonodynamic therapy enhanced by magnetophoretically controlled magnetic microbubbles
- Top Cited Papers
- 9 July 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 237, 115523
CRISPR/Cas12a-Assisted isothermal amplification for rapid and specific diagnosis of respiratory virus on an microfluidic platform
- 9 July 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 237, 115523
Top Cited PapersCRISPR/Cas12a-Assisted isothermal amplification for rapid and specific diagnosis of respiratory virus on an microfluidic platform